EP3774756A1 - Verfahren zur herstellung von chroman-6-olen mit kurzen seitenketten - Google Patents

Verfahren zur herstellung von chroman-6-olen mit kurzen seitenketten

Info

Publication number
EP3774756A1
EP3774756A1 EP19713808.4A EP19713808A EP3774756A1 EP 3774756 A1 EP3774756 A1 EP 3774756A1 EP 19713808 A EP19713808 A EP 19713808A EP 3774756 A1 EP3774756 A1 EP 3774756A1
Authority
EP
European Patent Office
Prior art keywords
range
solvents
formula
process according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19713808.4A
Other languages
English (en)
French (fr)
Inventor
Marcel Joray
Thomas Netscher
René Tobias STEMMLER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of EP3774756A1 publication Critical patent/EP3774756A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/723,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols

Definitions

  • the present invention is directed to a process for the manufacture of a compound of formula (III),
  • R 1 is Ci- 5 -alkyl
  • R 2 is either H or Ci- 2 -alkyl
  • R 4 is either H or Ci- 4 -alkoxy or Ci- 4 -alkyl
  • R 3 and R 5 are independently from each other either H or Ci- 4 -alkyl, and the first of the two solvents is water,
  • the second of the two solvents is selected from aliphatic Cs-s-hydrocarbons, cycloaliphatic Cs-s-hydrocarbons, dialkyl ethers and methyl-substituted benzenes and any mixture thereof.
  • reaction can be also carried out with isoprene according to various publications with yields in the range of 53-62% (see R. H. Cichewicz, V. A. Kenyon, S. Whitman, N. M. Morales, J. F. Arguello, T. R. Holman, P. Crews:“Redox Inactivation of Human 15-Lipoxygenase by Marine-Derived Meroditerpenes and Synthetic Chromanes: Archetypes for a Unique Class of Selective and Recyclable Inhibitors”, J. Am. Chem. Soc. 2004, 126, 14910-14920; G. P. Kalena, A. Jain, A.
  • Banerji «Amberlyst 15 Catalyzed Prenylation of Phenols: One-Step Synthesis of Benzopyrans.”, Molecules 1997, 2, 100-105 (using Amberlyst 15 in THF/heptane, 65-70° C, 2.5 h, 61%); V. K. Ahluwalia, K. K. Arora, R. S. Jolly:“Acid-catalysed condensation of isoprene with phenols. Formation of 2,2-dimethylchromans.”, J. Chem. Soc., Perkin Trans. 1 1982, 335-338 (H3PO4); F. Bigi, S. Carloni, R. Maggi, C. Muchetti, M.
  • prenyl acetate has been shown to react with HQ catalyzed by ln(OTf) 3 , a salt of the rare earth metal indium, (see V. Vece, J. Ricci, S. Poulain- Martini, P. Nava, Y. Carissan, S. Humbel, E. Duhach:“ I n ( 111 ) - Cat a lysed Tandem C-C and C-0 Bond Formation between Phenols and Allylic Acetates”, Eur. J. Org. Chem. 2010, 6239-6248.).
  • dichloromethane a halogenated solvent, had to be used.
  • Step 1 MeSOsH as solvent; 50 mol-% of P 2 Os, yield 91% (see F. Camps, J. Coll, A. Messeguer, M. A. Pericas, S. Spainrt, W. S. Bowers, D. M. Soderlund:“An Improved Procedure for the Preparation of 2,2-Dimethyl-4-chromanones.”, Synthesis 1980, 725-727.).
  • Step 2) LiAlH 4 , Et 2 0, yield 87% (see P. Anastasis, P. E. Brown:“Analogues of antijuvenile hormones.”, J. Chem. Soc., Perkin Trans. 1 1982, 2013-2018.).
  • the total yield is 79% over the two steps.
  • R 1 is Ci- 5 -alkyl
  • R 2 is either H or Ci- 2 -alkyl
  • R 4 is either H or Ci- 4 -alkoxy or Ci- 4 -alkyl
  • R 3 and R 5 are independently from each other either H or Ci- 4 -alkyl
  • the first of the two solvents is water
  • both the used acid catalyst and excess of compound of formula (I) are reusable, simply by separating the product phase from the phase containing catalyst and excess of compound of formula (I).
  • OR is preferably OH or acetate.
  • R 1 is preferably methyl.
  • R 2 is preferably H or methyl; more preferably R 2 is methyl.
  • R 4 is preferably either H or methoxy or methyl, more preferably R 4 is H or methoxy.
  • R 3 and R 5 are preferably independently from each other either H or methyl.
  • alkyl and“alkoxy” in the context of the present invention encompass linear alkyl and branched alkyl, and linear alkoxy and branched alkoxy, respectively.
  • Fig. 2-5 shows the synthesis of 2,2-dimethylchroman-6-ol (compound of formula (III- 1 )) starting from 1 ,4-hydroquinone (compound of formula (1-1 )) and 2-methylbut-3- en-2-ol (compound of formula (IIA-1 )).
  • Fig. 3 shows the synthesis of 2,2-dimethylchroman-6-ol (compound of formula (MI- 1 )) starting from 1 ,4-hydroquinone (compound of formula (1-1 )) and isoprene
  • FIG. 4 shows the synthesis of 2,2-dimethylchroman-6-ol (compound of formula (III- 1 )) starting from 1 ,4-hydroquinone (compound of formula (1-1 )) and a prenyl derivative (compound of formula (IIC-1 )).
  • Fig. 5 shows the synthesis of 2,2-dimethylchroman-6-ol (compound of formula (III- 1 )) starting from 1 ,4-hydroquinone (compound of formula (1-1 )) and prenol
  • the molar ratio of the compound of formula (I) to the compound of formula (IIA), (MB) or (IIC) is in the range of 6.0: 1 to 1.1 :1 , more preferably in the range of 4.0:1 to 1.3: 1 , even more preferably in the range of from 3.0: 1 to 1.5:1 , most preferably in the range of 2.5:1 to 1 .7:1 .
  • all embodiments of the present invention with regard to the starting materials and the preferences as given above are realized.
  • aliphatic Cs-s-hydrocarbons are hexane and heptane.
  • hexane encompasses n-hexane, as well as any mixture of the isomers of hexane. The same applies for heptane.
  • a preferred example of a cycloaliphatic Cs-s-hydrocarbon is cyclohexane.
  • the alkyl groups in the dialkyl ethers may be identical or different, preferably they are different.
  • the alkyl groups are aliphatic linear Ci- 5 -alkyl groups or branched C alkyl groups.
  • a preferred example of a dialkyl ether is methyl tert- butyl ether.
  • methyl-substituted benzenes are ortho-xylene, meta-xylene, para-xylene, mesitylene, pseudocumene, and toluene.
  • the second solvent is hexane, cyclohexane, heptane, ortho-xylene, meta-xylene, para-xylene, mesitylene, pseudocumene, methyl tert- butyl ether, or toluene, and any mixture thereof.
  • the second solvent is hexane, cyclohexane, heptane, ortho-xylene, meta-xylene, para-xylene, mesitylene, pseudocumene, methyl tert- butyl ether, or toluene.
  • the first of the two solvents is water and the second of the two solvents is selected from either mesitylene, pseudocumene, ortho-xylene, meta-xylene, para-xylene or toluene, more preferably the first of the two solvents is water and the second of the two solvents is selected from either ortho-xylene, meta-xylene, para-xylene or toluene, most preferably the first of the two solvents is water and the second of the two solvents is toluene.
  • the volume ratio of the first solvent to the second solvent during the reaction is in the range of 1 :4 to 4:1 , more preferably the volume ratio of the first solvent to the second solvent is in the range of 1 :3 to 3:1 , most preferably the volume ratio of the first solvent to the second solvent is in the range of 1 :2 to 2:1 .
  • the total amount of the two solvents is in the range of 1 to 8 kg, preferably in the range of 2 to 6 kg, more preferably in the range of 2.5 to 5.5 kg, per kg of the compound of formula (I).
  • all embodiments of the present invention with regard to the solvent and the preferences as given above are realized.
  • the water may be added as such to the reaction mixture or as an aqueous solution of an acid catalyst with the preferences as disclosed below, i.e. a mixture of water and the acid catalyst may be used.
  • the preferred amounts of water given above also encompass the water contained in the aqueous solution of the acid catalyst.
  • Suitable acid catalysts are Bronsted acids and Lewis acids and any mixture thereof.
  • Bronsted acids are sulfuric acid, phosphoric acid, acidic ion-exchange resins (e.g. Amberlyst 15), acidic clays (e.g. Montmorillonite K-10), zeolites (e.g. HSZ-360), hydrochloric acid, trifluoroacetic acid, trichloroacetic acid, acetic acid, formic acid, methanesulfonic acid, benzenesulfonic acid, para-toluenesulfonic acid, ethanesulfonic acid, trifluoromethanesulfonic acid, bis(perfluoroalkyl- sulfonyl)methanes (R’S0 2 )(R”S0 2 )CH 2 wherein R’ and R” each signify independently from each other a perfluoroalkyl group of the formula C n F 2n+i where n is an integer from 1 to 10, tris(perfluorosulfonyl)methane
  • pentafluorophenyl group (-C 6 F 5 ) and R” and R’” each signify an identical perfluoroalkyl group of the above formula C n F 2n+i , methanetrisulfonic acid, and bis(trifluormethylsulfonyl)imide, and any mixture thereof, whereby the use of single catalysts is preferred.
  • Lewis acids are Sc(OTf) 3 , Sc(NTf 2 ) 3 , ScCl 3 , Yb(OTf) 3 , YbCl 3 , Cu(OTf) 2 , FeCl 2 , Fe(OTf) 2 , ZnCl 2 , Zn(OTf) 2 , Zn(NTf 2 ) 3 , YCl 3 , Y(OTf) 3 , lnCl 3 , lnBr 3 , ln(OTf) 3 , ln(NTf 2 ) 3 , La(OTf) 3 , Ce(OTf) 3 , Sm(OTf) 3 , Gd(OTf) 3 , Bi(OTf) 3 in the absence or presence of 2,2-bipyridine and any mixture thereof, whereby the use of single catalysts is preferred.
  • the acid catalyst is sulfuric acid, hydrochloric acid, formic acid, Amberlyst 15, trifluoroacetic acid, or phosphoric acid or their aqueous
  • the acid catalyst is sulfuric acid, hydrochloric acid or Amberlyst 15, most preferably the acid catalyst is sulfuric acid. Mixtures of these catalysts may also be used.
  • the acid catalyst is sulfuric acid and the concentration of said sulfuric acid is in the range of from 0.1 to 10 mol/L, preferably wherein the concentration of said sulfuric acid is in the range of 0.4 to 4.0 mol/L.
  • the amount of the acid catalyst is in the range of 0.01 to 10 mol equivalents, more preferably in the range of 0.05 to 5 mol equivalents, most preferably in the range of 0.1 to 1 mol equivalents, relative to the amount of compound of formula (IIA), (MB), or (IIC).
  • the reaction is preferably carried out at a temperature in the range of 50 to 140°C, more preferably in the range of 60 to 120°C, even more preferably in the range of 70 to 100°C, most preferably in the range of 75 to 90° C.
  • the reaction is preferably carried out at a pressure in the range of 0.5 to 20 bar (absolute), more preferably at a pressure in the range of 0.7 to 10 bar (absolute), most preferably at a pressure in the range of 0.8 to 5 bar (absolute).
  • Example 1 Synthesis of 2.2-dimethylchroman-6-ol starting from 1 .4- hydroquinone and 2-methylbut-3-en-2-ol
  • the combined organic phases were washed with 100 ml. of brine (10 % aqueous NaCl solution), subsequently dried over sodium sulfate, filtered and evaporated at 40° C/200-10 mbar.
  • the heterogeneous, crude material (31 .5 g) was digested in 50 ml. of heptane/ethyl acetate (90/10 w/w) and filtered.
  • the filter cake (mostly HQ) was washed with 50 ml. of heptane/ethyl acetate (90/10 w/w).
  • the filtrate was concentrated in vacuo (40°C/200-10 mbar), furnishing crude product (14.4 g).
  • This material was purified by column chromatography; eluent gradient heptane to heptane/EtOAc 80:20 (w/w). The pure fractions were combined and concentrated in vacuo (40° C/200-10 mbar). The residue was taken up in 30 ml. of dichloromethane and subsequently evaporated again to dryness (40 ° C/200-0.1 mbar), furnishing 5.6 g of DMC as off-white crystals (31.4 mmol, 98.5% purity by qNMR, 37% yield).
  • the toluene solution was then concentrated in a rotary evaporator to furnish 29.60 g of crude DMC as beige oil (assay 75.4% by ql_C, a chemical yield of 78.7% relative to MBE).
  • the crude material was purified in a distillation apparatus equipped with a Vigreux column (20 cm) at 0.3 mbar and 125°C (internal temperature), furnishing one fraction: 22.40 g of DMC (assay 97.0% by quant. LC, 121.9 mmol, 76.5% isolated yield), mp. 74.5-75°C.
  • Example 3 Synthesis of 2.2-dimethylchroman-6-ol starting from 1.4- hydroquinone and 2-methylbut-3-en-2-ol: Recycling of catalyst and 1 .4- hydroquinone phase
  • a 1 .5 L 4-necked sulfonation flask equipped with argon inlet, magnetic stirrer, oil bath and thermometer was charged with 651 g aqueous phase from the previous run (carried out on the same scale as the present run; containing hydroquinone, approx. 3 mol equiv., -1 .17 mol, and sulfuric acid, -0.4 M, 0.78 mol, 0.5 mol equiv.
  • Example 6 Synthesis of 2.2-dimethylchroman-6-ol starting from 1 .4- hydroquinone and 2-methylbut-3-en-2-ol in the presence of Amberlyst 15 as acid catalyst A 200 ml. 4-necked sulfonation flask equipped with argon inlet, magnetic stirrer, oil bath and thermometer was charged with 8.0 g of 1 ,4-hydroquinone (72.2 mmol, 99.5%, 1 .9 mol equiv.) and 2-methyl-3-buten-2-ol (4.0 ml_, 39 mmol, 1 .0 mol equiv.), which were then suspended in 50 ml.
  • Example 14 Synthesis of 2.2-dimethylchroman-6-ol (“DM- chromanol”) starting from 1 .4-hydroquinone (“HQ”) and 2-methylbut-3-en-2-ol (“MBE”) according to the conditions disclosed in US 4,217,285 , i.e. in the presence of ZnCb, silica-alumina and concentrated hydrochloric acid
  • DM- chromanol 2.2-dimethylchroman-6-ol
  • HQ 1 .4-hydroquinone
  • MBE 2-methylbut-3-en-2-ol

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EP19713808.4A 2018-03-29 2019-03-29 Verfahren zur herstellung von chroman-6-olen mit kurzen seitenketten Withdrawn EP3774756A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18164861 2018-03-29
PCT/EP2019/058064 WO2019185900A1 (en) 2018-03-29 2019-03-29 Process for the manufacture of chroman-6-ols with short side chains

Publications (1)

Publication Number Publication Date
EP3774756A1 true EP3774756A1 (de) 2021-02-17

Family

ID=61837639

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19713808.4A Withdrawn EP3774756A1 (de) 2018-03-29 2019-03-29 Verfahren zur herstellung von chroman-6-olen mit kurzen seitenketten

Country Status (3)

Country Link
EP (1) EP3774756A1 (de)
CN (1) CN111936483A (de)
WO (1) WO2019185900A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022078924A1 (en) 2020-10-12 2022-04-21 Dsm Ip Assets B.V. New feed additives of fat-soluble vitamins
WO2022112585A1 (en) 2020-11-30 2022-06-02 Dsm Ip Assets B.V. New sugar-free formulations, their manufacture and use
WO2022112587A1 (en) 2020-11-30 2022-06-02 Dsm Ip Assets B.V. New formulations with reduced antioxidant content, their manufacture and use
EP4250959A1 (de) 2020-11-30 2023-10-04 DSM IP Assets B.V. Neue formulierungen mit reduziertem antioxidantgehalt, ihre herstellung und verwendung
WO2022112586A1 (en) 2020-11-30 2022-06-02 Dsm Ip Assets B.V. New sugar-free formulations, their manufacture and use
EP4262428A1 (de) 2020-12-18 2023-10-25 DSM IP Assets B.V. Milchersatz mit tierfreien formulierungen von fettlöslichen vitaminen
WO2022129433A1 (en) 2020-12-18 2022-06-23 Dsm Ip Assets B.V. Milk replacer comprising animal-free formulations of fat-soluble vitamins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755758A (fr) 1969-09-06 1971-02-15 Bayer Ag Procede de preparation de matieres cellulaires en polyurethanesen presence de stabilisateurs de coloration
US4217285A (en) * 1976-09-29 1980-08-12 Nisshin Flour Milling Co., Ltd. Process for the preparation of Dl-α-tocopherol of high purity
DE59610172D1 (de) * 1996-01-05 2003-04-03 Hoffmann La Roche Verfahren zur Herstellung von d,l-alpha-Tocopherol in Gegenwart einer Perfluoralkylensulfonsäure als Katalysator
CN100398532C (zh) * 2003-07-08 2008-07-02 帝斯曼知识产权资产管理有限公司 用铋催化剂制备生育酚
ATE411307T1 (de) * 2003-12-05 2008-10-15 Dsm Ip Assets Bv Verfahren zur herstellung von alkenylierten hydroxylierten aromatischen verbindungen, von chromanverbindungen und deren acylierten derivaten

Also Published As

Publication number Publication date
CN111936483A (zh) 2020-11-13
WO2019185900A1 (en) 2019-10-03

Similar Documents

Publication Publication Date Title
EP3774756A1 (de) Verfahren zur herstellung von chroman-6-olen mit kurzen seitenketten
CN109153661B (zh) 用于纯化大麻素化合物的方法
FI60194C (fi) Foerfarande foer framstaellning av bensil-monoketaler
US20100298579A1 (en) Process for preparing synthetic cannabinoids
EP2058320B1 (de) Verfahren zur Herstellung von wasserlöslichen Phosphonooxymethyl-Derivaten aus Alkohol und Phenol
US7186850B2 (en) Synthesis of cannabinoids
US5107030A (en) Method of making 2,7-dimethyl-2,4,6-octatrienedial and derivatives thereof
EP2546226B1 (de) 1-methoxyl-2,6,10-trimethyl-1,3,5,9-undec-tetraen sowie verfahren zu seiner herstellung und verwendung
CN113603568A (zh) 一种大麻二酚的制备方法
Erdtman et al. Aucuparin and methoxyaucuparin, two phenolic biphenyl derivatives from the heartwood of Sorbus aucuparia (L.)
US5387718A (en) Method of manufacturing alkylphenyl alkyl ethers or alkylphenyl alkyl thioethers
US6329535B1 (en) Process for preparing esterified chroman compounds
CN112047815B (zh) 一种大麻二酚类化合物的制备方法
WO2015028463A1 (en) Formation of chromanes and chromenes by using silver(i) or gold(i) salts or complexes
RU2247707C2 (ru) Способ получения 4-метоксиметил-2,3,5,6-тетрафторбензолметанола
US20050261513A1 (en) Process for producing indenol esters or ethers
KR102247402B1 (ko) 시클로부탄테트라카르복실산 및 그 무수물의 제조 방법
KR20210119398A (ko) 4-(2,2,3,3-테트라플루오로프로필)모르폴린을 제조하는 방법
FRIEDMAN et al. The synthesis of some alkoxy-and alkyl-substituted tetraphenylcyclopentadienones
Morikawa et al. Sc (OTf) 3-catalyzed cyclooligomerization of 2, 4-dialkoxybenzyl alcohols. Formation of resorcin [n] arene peralkyl ethers
US7820836B2 (en) Process for the manufacture of hydroxylated isoflavones
US5292947A (en) Process for preparing alkylsulfonic anhydrides
GB2083071A (en) Process for preparing 2,5-dimethyl-2,4-hexadiene
KR20020074263A (ko) 에스테르화된 크로만 화합물의 제조방법
US20110196170A1 (en) Method for producing astaxanthin dimethyldisuccinate

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200925

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20221006

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230217